Browsing for next random stock pick!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BIOL - I can see this but right now cash stuck.
STEM ($1.58) - Break out @ above $1.59 here. Watch it.
MNGA ($1.60) Moving back down to my support area here.
KBIO - T2 $2.39! Let's see this hit $2.24 first though. Stop Limit/Trailing Stop Limit: $2.05
VTUS - Totally agree. I wanted to grab more yesterday but didn't have the opportunity. Did you see the last two days..man did they drive this stock down before June 19th. Folks were shaken.
VTUS - Think pretty much the sell off is done early this morning. Mid-day run hopefully up to June 19.
END -Breakdown below $1.34, no support in area just below here. Have to careful here. I want to see this stay above $1.34. Still think this will spring back into action.
CPRX ($2.38) Still holding here.
GIGA - Very nice quick move on this bro!
VTUS - Hmmm..need to find out why it's dropping here FDA date is 2/days away...
ETRM - Currently halted pending news I believe.
AMCO- Watch for possible break out above .24 here might bring back .30
YGE Azy?
Back in business as usual today! Missed out a little action yesterday b/c of work related. Did get opportunity to average down on AMCO to .30 though. Hope today will be green.
NAVB - Was it Adam F that killed it today? Anyone know what's the deal here with today's GOOD news vs. stock shot down? Ref. to U.S. FDA Approves Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection for Expanded Use in Head and Neck Cancer Sentinel Lymph Node Biopsy?
NAVB - Interesting to see Monday. Other release: http://www.fool.com/investing/general/2014/06/13/why-navidea-biopharmaceuticals-inc-shares-briefly.aspx
NAVB - Apparently Adam F did a one hit wonder with a killer article that shot this stock down IMO. This guy is a nightmare...experienced it with CPRX. Ref. http://www.thestreet.com/story/12741934/1/biotech-stock-mailbag-vanda-navidea-provectus.html?puc=yahoo&cm_ven=YAHOO
MNGA - Energy sector is definitely in play now.
VTUS - Cheers to next week for folks holding VTUS! Let's see this break out before June 19.
VTUS - It will break out before June 19. Nice closing also considering it's Friday. Next week will be "the week". It won't be flirting anymore come next week.
ARQL ($1.46) Price check. Reminder ARQL Phase 2 (06.30.2014) <link back>
BLFS ($2.34) This one seems to be doing pretty good. <Link Back>
And there you go saying today was BORING! LoL.
Agreed. This is a bounce play for me b/c I saw the heavy pullback almost retracing 50% sum sum.. anyways should be good.
BOARD: I bought two today. Let's see how it goes next week.
AMCO 06.13.2014 $0.349
END 06.13.2014 $1.389
stock_observer_77- Are you planning to hold through June 19th?
END - An end is to a new beginning! My second go round with END here. END 06.10.2014 @$1.61 06.10.2014 @$1.95 21.118 %
Cheers SwingKing!
OT: I use TradeKing
END IN @$1.389 couple pennies behind what I wanted but was researching at the time..by the time I decided to pull trigger it moved up an inch. Anyways here's to the rumors.
BOT 1,200 END ENDEAVOUR INTERNATIONAL Limit $1.39 1.36 1.37 Day 06/13/14 2:31 PM ET SVI-5981351195/2 Executed @ $1.3899
Like a hawk here with VTUS!
END ($1.36) Looking to enter EOD here. $1.35 -$1.36
NAVB ($1.76) Don't know why this is down when good news in air.
Navidea confirms FDA approval of expanded use for Lymphoseek
Navidea Biopharmaceuticals announced that the FDA has approved the Supplemental New Drug Application for the expanded use of Lymphoseek Injection indicated for guiding sentinel lymph node biopsy in head and neck cancer patients with squamous cell carcinoma of the oral cavity. Lymphoseek becomes the first and only FDA-approved radiopharmaceutical application for sentinel lymph node detection and was first approved in March 2013 for lymphatic mapping in breast cancer and melanoma patients.
Ref.http://www.theflyonthewall.com/permalinks/entry.php/NAVBid2025009/NAVB-Navidea-confirms-FDA-approval-of-expanded-use-for-Lymphoseek
SYN - Looks like a mid - day runner here.
ANR ($3.60) Nice! Tooo bad for me though.
END - The end of END might be a new beginning here.
AMCO - Still holding and looking good IMO.
I have to admit "I am a stock trading junkie" LOL